Bupropion hydrochloride extended-release tablets are the generic equivalent to GlaxoSmithKline’s Wellbutrin XL product, which is indicated for the treatment of major depressive disorder. Watson intends to launch the product immediately.
Bupropion hydrochloride extended-release tablets are the generic equivalent to GlaxoSmithKline’s Wellbutrin XL product, which is indicated for the treatment of major depressive disorder. Watson intends to launch the product immediately.